Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Work In Process (2016 - 2025)

Utah Medical Products has reported Work In Process over the past 15 years, most recently at $1.6 million for Q4 2025.

  • Quarterly results put Work In Process at $1.6 million for Q4 2025, up 15.06% from a year ago — trailing twelve months through Dec 2025 was $1.6 million (up 15.06% YoY), and the annual figure for FY2025 was $1.6 million, up 15.06%.
  • Work In Process for Q4 2025 was $1.6 million at Utah Medical Products, up from $1.4 million in the prior quarter.
  • Over the last five years, Work In Process for UTMD hit a ceiling of $1.7 million in Q3 2023 and a floor of $1.2 million in Q1 2021.
  • Median Work In Process over the past 5 years was $1.4 million (2023), compared with a mean of $1.4 million.
  • Peak annual rise in Work In Process hit 38.23% in 2022, while the deepest fall reached 14.66% in 2022.
  • Utah Medical Products' Work In Process stood at $1.4 million in 2021, then dropped by 14.66% to $1.2 million in 2022, then increased by 25.98% to $1.5 million in 2023, then decreased by 5.92% to $1.4 million in 2024, then rose by 15.06% to $1.6 million in 2025.
  • The last three reported values for Work In Process were $1.6 million (Q4 2025), $1.4 million (Q4 2024), and $1.4 million (Q3 2024) per Business Quant data.